To evaluate the relative amount of NO released into the culture medium by each of the NOS isoforms, we treated NPC cells with either a broad-spectrum NOS inhibitor (L-NAME),22 or a selective NOS1 or NOS2 inhibitor (N-PLA or 1400W, respectively). The gene discussed is NOS2; the disease is nasopharyngeal carcinoma.